nodes	percent_of_prediction	percent_of_DWPC	metapath
Pregabalin—Cardiac arrest—Fluorouracil—head and neck cancer	0.00203	0.00203	CcSEcCtD
Pregabalin—Skin exfoliation—Docetaxel—head and neck cancer	0.00203	0.00203	CcSEcCtD
Pregabalin—Candida infection—Docetaxel—head and neck cancer	0.00203	0.00203	CcSEcCtD
Pregabalin—Fluid retention—Docetaxel—head and neck cancer	0.00201	0.00201	CcSEcCtD
Pregabalin—Ataxia—Fluorouracil—head and neck cancer	0.00201	0.00201	CcSEcCtD
Pregabalin—Neuropathy—Docetaxel—head and neck cancer	0.00199	0.00199	CcSEcCtD
Pregabalin—Alopecia—Vinblastine—head and neck cancer	0.00199	0.00199	CcSEcCtD
Pregabalin—Dry skin—Fluorouracil—head and neck cancer	0.00196	0.00196	CcSEcCtD
Pregabalin—Oesophagitis—Docetaxel—head and neck cancer	0.00194	0.00194	CcSEcCtD
Pregabalin—Neoplasm—Docetaxel—head and neck cancer	0.00192	0.00192	CcSEcCtD
Pregabalin—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00191	0.00191	CcSEcCtD
Pregabalin—Pulmonary oedema—Docetaxel—head and neck cancer	0.00189	0.00189	CcSEcCtD
Pregabalin—Muscular weakness—Fluorouracil—head and neck cancer	0.00188	0.00188	CcSEcCtD
Pregabalin—Angiopathy—Hydroxyurea—head and neck cancer	0.00186	0.00186	CcSEcCtD
Pregabalin—Dysphagia—Fluorouracil—head and neck cancer	0.00184	0.00184	CcSEcCtD
Pregabalin—Sepsis—Docetaxel—head and neck cancer	0.00184	0.00184	CcSEcCtD
Pregabalin—Chills—Hydroxyurea—head and neck cancer	0.00184	0.00184	CcSEcCtD
Pregabalin—Eosinophilia—Fluorouracil—head and neck cancer	0.00183	0.00183	CcSEcCtD
Pregabalin—Ill-defined disorder—Vinblastine—head and neck cancer	0.00182	0.00182	CcSEcCtD
Pregabalin—Alopecia—Hydroxyurea—head and neck cancer	0.00181	0.00181	CcSEcCtD
Pregabalin—Anaemia—Vinblastine—head and neck cancer	0.00181	0.00181	CcSEcCtD
Pregabalin—Angina pectoris—Fluorouracil—head and neck cancer	0.0018	0.0018	CcSEcCtD
Pregabalin—Phlebitis—Docetaxel—head and neck cancer	0.00179	0.00179	CcSEcCtD
Pregabalin—Thrombophlebitis—Docetaxel—head and neck cancer	0.00178	0.00178	CcSEcCtD
Pregabalin—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00177	0.00177	CcSEcCtD
Pregabalin—Malaise—Vinblastine—head and neck cancer	0.00177	0.00177	CcSEcCtD
Pregabalin—Vertigo—Vinblastine—head and neck cancer	0.00176	0.00176	CcSEcCtD
Pregabalin—Leukopenia—Vinblastine—head and neck cancer	0.00175	0.00175	CcSEcCtD
Pregabalin—Pancytopenia—Fluorouracil—head and neck cancer	0.00175	0.00175	CcSEcCtD
Pregabalin—Deafness—Docetaxel—head and neck cancer	0.00172	0.00172	CcSEcCtD
Pregabalin—Cardiac failure congestive—Docetaxel—head and neck cancer	0.0017	0.0017	CcSEcCtD
Pregabalin—Convulsion—Vinblastine—head and neck cancer	0.0017	0.0017	CcSEcCtD
Pregabalin—Hypertension—Vinblastine—head and neck cancer	0.00169	0.00169	CcSEcCtD
Pregabalin—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00168	0.00168	CcSEcCtD
Pregabalin—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00166	0.00166	CcSEcCtD
Pregabalin—Pneumonia—Fluorouracil—head and neck cancer	0.00165	0.00165	CcSEcCtD
Pregabalin—Anaemia—Hydroxyurea—head and neck cancer	0.00165	0.00165	CcSEcCtD
Pregabalin—Discomfort—Vinblastine—head and neck cancer	0.00165	0.00165	CcSEcCtD
Pregabalin—Hot flush—Docetaxel—head and neck cancer	0.00165	0.00165	CcSEcCtD
Pregabalin—Infestation NOS—Fluorouracil—head and neck cancer	0.00164	0.00164	CcSEcCtD
Pregabalin—Infestation—Fluorouracil—head and neck cancer	0.00164	0.00164	CcSEcCtD
Pregabalin—Menopausal symptoms—Docetaxel—head and neck cancer	0.00163	0.00163	CcSEcCtD
Pregabalin—Atrial fibrillation—Docetaxel—head and neck cancer	0.00163	0.00163	CcSEcCtD
Pregabalin—Visual disturbance—Docetaxel—head and neck cancer	0.00163	0.00163	CcSEcCtD
Pregabalin—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00162	0.00162	CcSEcCtD
Pregabalin—Renal impairment—Docetaxel—head and neck cancer	0.00162	0.00162	CcSEcCtD
Pregabalin—Myocardial infarction—Fluorouracil—head and neck cancer	0.00161	0.00161	CcSEcCtD
Pregabalin—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00161	0.00161	CcSEcCtD
Pregabalin—Dermatitis bullous—Docetaxel—head and neck cancer	0.00161	0.00161	CcSEcCtD
Pregabalin—Malaise—Hydroxyurea—head and neck cancer	0.00161	0.00161	CcSEcCtD
Pregabalin—Stomatitis—Fluorouracil—head and neck cancer	0.0016	0.0016	CcSEcCtD
Pregabalin—Urinary tract infection—Fluorouracil—head and neck cancer	0.0016	0.0016	CcSEcCtD
Pregabalin—Conjunctivitis—Fluorouracil—head and neck cancer	0.0016	0.0016	CcSEcCtD
Pregabalin—Leukopenia—Hydroxyurea—head and neck cancer	0.0016	0.0016	CcSEcCtD
Pregabalin—Cardiac failure—Docetaxel—head and neck cancer	0.00158	0.00158	CcSEcCtD
Pregabalin—Lethargy—Docetaxel—head and neck cancer	0.00157	0.00157	CcSEcCtD
Pregabalin—Thrombocytopenia—Vinblastine—head and neck cancer	0.00156	0.00156	CcSEcCtD
Pregabalin—Epistaxis—Fluorouracil—head and neck cancer	0.00155	0.00155	CcSEcCtD
Pregabalin—Convulsion—Hydroxyurea—head and neck cancer	0.00155	0.00155	CcSEcCtD
Pregabalin—Hyponatraemia—Docetaxel—head and neck cancer	0.00155	0.00155	CcSEcCtD
Pregabalin—Sinusitis—Fluorouracil—head and neck cancer	0.00154	0.00154	CcSEcCtD
Pregabalin—Pain in extremity—Docetaxel—head and neck cancer	0.00154	0.00154	CcSEcCtD
Pregabalin—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.00154	0.00154	CcSEcCtD
Pregabalin—Anorexia—Vinblastine—head and neck cancer	0.00152	0.00152	CcSEcCtD
Pregabalin—Migraine—Docetaxel—head and neck cancer	0.00152	0.00152	CcSEcCtD
Pregabalin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00151	0.00151	CcSEcCtD
Pregabalin—Discomfort—Hydroxyurea—head and neck cancer	0.0015	0.0015	CcSEcCtD
Pregabalin—Haemoglobin—Fluorouracil—head and neck cancer	0.00148	0.00148	CcSEcCtD
Pregabalin—Rhinitis—Fluorouracil—head and neck cancer	0.00148	0.00148	CcSEcCtD
Pregabalin—Haemorrhage—Fluorouracil—head and neck cancer	0.00148	0.00148	CcSEcCtD
Pregabalin—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00147	0.00147	CcSEcCtD
Pregabalin—Pharyngitis—Fluorouracil—head and neck cancer	0.00147	0.00147	CcSEcCtD
Pregabalin—Oedema—Hydroxyurea—head and neck cancer	0.00146	0.00146	CcSEcCtD
Pregabalin—Ataxia—Docetaxel—head and neck cancer	0.00145	0.00145	CcSEcCtD
Pregabalin—Infection—Hydroxyurea—head and neck cancer	0.00145	0.00145	CcSEcCtD
Pregabalin—Paraesthesia—Vinblastine—head and neck cancer	0.00144	0.00144	CcSEcCtD
Pregabalin—Dehydration—Docetaxel—head and neck cancer	0.00143	0.00143	CcSEcCtD
Pregabalin—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00143	0.00143	CcSEcCtD
Pregabalin—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00143	0.00143	CcSEcCtD
Pregabalin—Liver function test abnormal—Docetaxel—head and neck cancer	0.00142	0.00142	CcSEcCtD
Pregabalin—Skin disorder—Hydroxyurea—head and neck cancer	0.00142	0.00142	CcSEcCtD
Pregabalin—Dry skin—Docetaxel—head and neck cancer	0.00141	0.00141	CcSEcCtD
Pregabalin—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00141	0.00141	CcSEcCtD
Pregabalin—Breast disorder—Docetaxel—head and neck cancer	0.00139	0.00139	CcSEcCtD
Pregabalin—Anorexia—Hydroxyurea—head and neck cancer	0.00139	0.00139	CcSEcCtD
Pregabalin—Decreased appetite—Vinblastine—head and neck cancer	0.00139	0.00139	CcSEcCtD
Pregabalin—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00139	0.00139	CcSEcCtD
Pregabalin—Cramp muscle—Docetaxel—head and neck cancer	0.00139	0.00139	CcSEcCtD
Pregabalin—Nasopharyngitis—Docetaxel—head and neck cancer	0.00138	0.00138	CcSEcCtD
Pregabalin—Pain—Vinblastine—head and neck cancer	0.00137	0.00137	CcSEcCtD
Pregabalin—Constipation—Vinblastine—head and neck cancer	0.00137	0.00137	CcSEcCtD
Pregabalin—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00136	0.00136	CcSEcCtD
Pregabalin—Dysphagia—Docetaxel—head and neck cancer	0.00133	0.00133	CcSEcCtD
Pregabalin—Arrhythmia—Fluorouracil—head and neck cancer	0.00132	0.00132	CcSEcCtD
Pregabalin—Feeling abnormal—Vinblastine—head and neck cancer	0.00132	0.00132	CcSEcCtD
Pregabalin—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00131	0.00131	CcSEcCtD
Pregabalin—Alopecia—Fluorouracil—head and neck cancer	0.0013	0.0013	CcSEcCtD
Pregabalin—Dyspnoea—Hydroxyurea—head and neck cancer	0.0013	0.0013	CcSEcCtD
Pregabalin—Angina pectoris—Docetaxel—head and neck cancer	0.0013	0.0013	CcSEcCtD
Pregabalin—Somnolence—Hydroxyurea—head and neck cancer	0.0013	0.0013	CcSEcCtD
Pregabalin—Decreased appetite—Hydroxyurea—head and neck cancer	0.00127	0.00127	CcSEcCtD
Pregabalin—Pancytopenia—Docetaxel—head and neck cancer	0.00126	0.00126	CcSEcCtD
Pregabalin—Abdominal pain—Vinblastine—head and neck cancer	0.00126	0.00126	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00126	0.00126	CcSEcCtD
Pregabalin—Fatigue—Hydroxyurea—head and neck cancer	0.00126	0.00126	CcSEcCtD
Pregabalin—Constipation—Hydroxyurea—head and neck cancer	0.00125	0.00125	CcSEcCtD
Pregabalin—Pain—Hydroxyurea—head and neck cancer	0.00125	0.00125	CcSEcCtD
Pregabalin—Neutropenia—Docetaxel—head and neck cancer	0.00125	0.00125	CcSEcCtD
Pregabalin—Weight increased—Docetaxel—head and neck cancer	0.00121	0.00121	CcSEcCtD
Pregabalin—Vision blurred—Fluorouracil—head and neck cancer	0.00121	0.00121	CcSEcCtD
Pregabalin—Weight decreased—Docetaxel—head and neck cancer	0.0012	0.0012	CcSEcCtD
Pregabalin—Feeling abnormal—Hydroxyurea—head and neck cancer	0.0012	0.0012	CcSEcCtD
Pregabalin—Pneumonia—Docetaxel—head and neck cancer	0.00119	0.00119	CcSEcCtD
Pregabalin—Anaemia—Fluorouracil—head and neck cancer	0.00119	0.00119	CcSEcCtD
Pregabalin—Infestation NOS—Docetaxel—head and neck cancer	0.00119	0.00119	CcSEcCtD
Pregabalin—Infestation—Docetaxel—head and neck cancer	0.00119	0.00119	CcSEcCtD
Pregabalin—Hypersensitivity—Vinblastine—head and neck cancer	0.00118	0.00118	CcSEcCtD
Pregabalin—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00118	0.00118	CcSEcCtD
Pregabalin—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00117	0.00117	CcSEcCtD
Pregabalin—Renal failure—Docetaxel—head and neck cancer	0.00117	0.00117	CcSEcCtD
Pregabalin—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00116	0.00116	CcSEcCtD
Pregabalin—Myocardial infarction—Docetaxel—head and neck cancer	0.00116	0.00116	CcSEcCtD
Pregabalin—Stomatitis—Docetaxel—head and neck cancer	0.00116	0.00116	CcSEcCtD
Pregabalin—Jaundice—Docetaxel—head and neck cancer	0.00116	0.00116	CcSEcCtD
Pregabalin—Conjunctivitis—Docetaxel—head and neck cancer	0.00115	0.00115	CcSEcCtD
Pregabalin—Body temperature increased—Hydroxyurea—head and neck cancer	0.00115	0.00115	CcSEcCtD
Pregabalin—Leukopenia—Fluorouracil—head and neck cancer	0.00115	0.00115	CcSEcCtD
Pregabalin—Asthenia—Vinblastine—head and neck cancer	0.00115	0.00115	CcSEcCtD
Pregabalin—Epistaxis—Docetaxel—head and neck cancer	0.00112	0.00112	CcSEcCtD
Pregabalin—Convulsion—Fluorouracil—head and neck cancer	0.00111	0.00111	CcSEcCtD
Pregabalin—Myalgia—Fluorouracil—head and neck cancer	0.00109	0.00109	CcSEcCtD
Pregabalin—Chest pain—Fluorouracil—head and neck cancer	0.00109	0.00109	CcSEcCtD
Pregabalin—Diarrhoea—Vinblastine—head and neck cancer	0.00109	0.00109	CcSEcCtD
Pregabalin—Discomfort—Fluorouracil—head and neck cancer	0.00108	0.00108	CcSEcCtD
Pregabalin—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00107	0.00107	CcSEcCtD
Pregabalin—Haemoglobin—Docetaxel—head and neck cancer	0.00107	0.00107	CcSEcCtD
Pregabalin—Rhinitis—Docetaxel—head and neck cancer	0.00107	0.00107	CcSEcCtD
Pregabalin—Hepatitis—Docetaxel—head and neck cancer	0.00107	0.00107	CcSEcCtD
Pregabalin—Haemorrhage—Docetaxel—head and neck cancer	0.00107	0.00107	CcSEcCtD
Pregabalin—Hypoaesthesia—Docetaxel—head and neck cancer	0.00106	0.00106	CcSEcCtD
Pregabalin—Confusional state—Fluorouracil—head and neck cancer	0.00106	0.00106	CcSEcCtD
Pregabalin—Pharyngitis—Docetaxel—head and neck cancer	0.00106	0.00106	CcSEcCtD
Pregabalin—Dizziness—Vinblastine—head and neck cancer	0.00106	0.00106	CcSEcCtD
Pregabalin—Urinary tract disorder—Docetaxel—head and neck cancer	0.00105	0.00105	CcSEcCtD
Pregabalin—Oedema peripheral—Docetaxel—head and neck cancer	0.00105	0.00105	CcSEcCtD
Pregabalin—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00105	0.00105	CcSEcCtD
Pregabalin—Oedema—Fluorouracil—head and neck cancer	0.00105	0.00105	CcSEcCtD
Pregabalin—Connective tissue disorder—Docetaxel—head and neck cancer	0.00105	0.00105	CcSEcCtD
Pregabalin—Asthenia—Hydroxyurea—head and neck cancer	0.00105	0.00105	CcSEcCtD
Pregabalin—Urethral disorder—Docetaxel—head and neck cancer	0.00104	0.00104	CcSEcCtD
Pregabalin—Infection—Fluorouracil—head and neck cancer	0.00104	0.00104	CcSEcCtD
Pregabalin—Nervous system disorder—Fluorouracil—head and neck cancer	0.00103	0.00103	CcSEcCtD
Pregabalin—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00103	0.00103	CcSEcCtD
Pregabalin—Visual impairment—Docetaxel—head and neck cancer	0.00103	0.00103	CcSEcCtD
Pregabalin—Tachycardia—Fluorouracil—head and neck cancer	0.00102	0.00102	CcSEcCtD
Pregabalin—Vomiting—Vinblastine—head and neck cancer	0.00102	0.00102	CcSEcCtD
Pregabalin—Erythema multiforme—Docetaxel—head and neck cancer	0.00101	0.00101	CcSEcCtD
Pregabalin—Headache—Vinblastine—head and neck cancer	0.001	0.001	CcSEcCtD
Pregabalin—Anorexia—Fluorouracil—head and neck cancer	0.001	0.001	CcSEcCtD
Pregabalin—Diarrhoea—Hydroxyurea—head and neck cancer	0.000997	0.000997	CcSEcCtD
Pregabalin—Eye disorder—Docetaxel—head and neck cancer	0.000996	0.000996	CcSEcCtD
Pregabalin—Cardiac disorder—Docetaxel—head and neck cancer	0.000989	0.000989	CcSEcCtD
Pregabalin—Flushing—Docetaxel—head and neck cancer	0.000989	0.000989	CcSEcCtD
Pregabalin—Hypotension—Fluorouracil—head and neck cancer	0.00098	0.00098	CcSEcCtD
Pregabalin—Angiopathy—Docetaxel—head and neck cancer	0.000967	0.000967	CcSEcCtD
Pregabalin—Dizziness—Hydroxyurea—head and neck cancer	0.000964	0.000964	CcSEcCtD
Pregabalin—Immune system disorder—Docetaxel—head and neck cancer	0.000963	0.000963	CcSEcCtD
Pregabalin—Mediastinal disorder—Docetaxel—head and neck cancer	0.000961	0.000961	CcSEcCtD
Pregabalin—Chills—Docetaxel—head and neck cancer	0.000956	0.000956	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000956	0.000956	CcSEcCtD
Pregabalin—Arrhythmia—Docetaxel—head and neck cancer	0.000952	0.000952	CcSEcCtD
Pregabalin—Nausea—Vinblastine—head and neck cancer	0.000949	0.000949	CcSEcCtD
Pregabalin—Insomnia—Fluorouracil—head and neck cancer	0.000949	0.000949	CcSEcCtD
Pregabalin—Paraesthesia—Fluorouracil—head and neck cancer	0.000942	0.000942	CcSEcCtD
Pregabalin—Alopecia—Docetaxel—head and neck cancer	0.000942	0.000942	CcSEcCtD
Pregabalin—Dyspnoea—Fluorouracil—head and neck cancer	0.000935	0.000935	CcSEcCtD
Pregabalin—Mental disorder—Docetaxel—head and neck cancer	0.000934	0.000934	CcSEcCtD
Pregabalin—Somnolence—Fluorouracil—head and neck cancer	0.000933	0.000933	CcSEcCtD
Pregabalin—Malnutrition—Docetaxel—head and neck cancer	0.000928	0.000928	CcSEcCtD
Pregabalin—Vomiting—Hydroxyurea—head and neck cancer	0.000927	0.000927	CcSEcCtD
Pregabalin—Rash—Hydroxyurea—head and neck cancer	0.000919	0.000919	CcSEcCtD
Pregabalin—Dermatitis—Hydroxyurea—head and neck cancer	0.000918	0.000918	CcSEcCtD
Pregabalin—Headache—Hydroxyurea—head and neck cancer	0.000913	0.000913	CcSEcCtD
Pregabalin—Decreased appetite—Fluorouracil—head and neck cancer	0.000912	0.000912	CcSEcCtD
Pregabalin—Dysgeusia—Docetaxel—head and neck cancer	0.000909	0.000909	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000906	0.000906	CcSEcCtD
Pregabalin—Back pain—Docetaxel—head and neck cancer	0.000897	0.000897	CcSEcCtD
Pregabalin—Pain—Fluorouracil—head and neck cancer	0.000897	0.000897	CcSEcCtD
Pregabalin—Muscle spasms—Docetaxel—head and neck cancer	0.000892	0.000892	CcSEcCtD
Pregabalin—Nausea—Hydroxyurea—head and neck cancer	0.000866	0.000866	CcSEcCtD
Pregabalin—Feeling abnormal—Fluorouracil—head and neck cancer	0.000865	0.000865	CcSEcCtD
Pregabalin—Anaemia—Docetaxel—head and neck cancer	0.000858	0.000858	CcSEcCtD
Pregabalin—Urticaria—Fluorouracil—head and neck cancer	0.000833	0.000833	CcSEcCtD
Pregabalin—Syncope—Docetaxel—head and neck cancer	0.000832	0.000832	CcSEcCtD
Pregabalin—Leukopenia—Docetaxel—head and neck cancer	0.000831	0.000831	CcSEcCtD
Pregabalin—Body temperature increased—Fluorouracil—head and neck cancer	0.000829	0.000829	CcSEcCtD
Pregabalin—Palpitations—Docetaxel—head and neck cancer	0.00082	0.00082	CcSEcCtD
Pregabalin—Loss of consciousness—Docetaxel—head and neck cancer	0.000815	0.000815	CcSEcCtD
Pregabalin—Cough—Docetaxel—head and neck cancer	0.00081	0.00081	CcSEcCtD
Pregabalin—Convulsion—Docetaxel—head and neck cancer	0.000804	0.000804	CcSEcCtD
Pregabalin—Hypertension—Docetaxel—head and neck cancer	0.000801	0.000801	CcSEcCtD
Pregabalin—Myalgia—Docetaxel—head and neck cancer	0.00079	0.00079	CcSEcCtD
Pregabalin—Arthralgia—Docetaxel—head and neck cancer	0.00079	0.00079	CcSEcCtD
Pregabalin—Chest pain—Docetaxel—head and neck cancer	0.00079	0.00079	CcSEcCtD
Pregabalin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000784	0.000784	CcSEcCtD
Pregabalin—Hypersensitivity—Fluorouracil—head and neck cancer	0.000773	0.000773	CcSEcCtD
Pregabalin—Dry mouth—Docetaxel—head and neck cancer	0.000773	0.000773	CcSEcCtD
Pregabalin—Confusional state—Docetaxel—head and neck cancer	0.000764	0.000764	CcSEcCtD
Pregabalin—Anaphylactic shock—Docetaxel—head and neck cancer	0.000757	0.000757	CcSEcCtD
Pregabalin—Oedema—Docetaxel—head and neck cancer	0.000757	0.000757	CcSEcCtD
Pregabalin—Infection—Docetaxel—head and neck cancer	0.000752	0.000752	CcSEcCtD
Pregabalin—Shock—Docetaxel—head and neck cancer	0.000745	0.000745	CcSEcCtD
Pregabalin—Nervous system disorder—Docetaxel—head and neck cancer	0.000743	0.000743	CcSEcCtD
Pregabalin—Pruritus—Fluorouracil—head and neck cancer	0.000742	0.000742	CcSEcCtD
Pregabalin—Thrombocytopenia—Docetaxel—head and neck cancer	0.000741	0.000741	CcSEcCtD
Pregabalin—Tachycardia—Docetaxel—head and neck cancer	0.000739	0.000739	CcSEcCtD
Pregabalin—Skin disorder—Docetaxel—head and neck cancer	0.000736	0.000736	CcSEcCtD
Pregabalin—Anorexia—Docetaxel—head and neck cancer	0.000722	0.000722	CcSEcCtD
Pregabalin—Diarrhoea—Fluorouracil—head and neck cancer	0.000718	0.000718	CcSEcCtD
Pregabalin—Hypotension—Docetaxel—head and neck cancer	0.000708	0.000708	CcSEcCtD
Pregabalin—Dizziness—Fluorouracil—head and neck cancer	0.000694	0.000694	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00069	0.00069	CcSEcCtD
Pregabalin—Insomnia—Docetaxel—head and neck cancer	0.000685	0.000685	CcSEcCtD
Pregabalin—Paraesthesia—Docetaxel—head and neck cancer	0.00068	0.00068	CcSEcCtD
Pregabalin—Dyspnoea—Docetaxel—head and neck cancer	0.000675	0.000675	CcSEcCtD
Pregabalin—Somnolence—Docetaxel—head and neck cancer	0.000673	0.000673	CcSEcCtD
Pregabalin—Vomiting—Fluorouracil—head and neck cancer	0.000667	0.000667	CcSEcCtD
Pregabalin—Rash—Fluorouracil—head and neck cancer	0.000662	0.000662	CcSEcCtD
Pregabalin—Dermatitis—Fluorouracil—head and neck cancer	0.000661	0.000661	CcSEcCtD
Pregabalin—Decreased appetite—Docetaxel—head and neck cancer	0.000658	0.000658	CcSEcCtD
Pregabalin—Headache—Fluorouracil—head and neck cancer	0.000657	0.000657	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000654	0.000654	CcSEcCtD
Pregabalin—Fatigue—Docetaxel—head and neck cancer	0.000653	0.000653	CcSEcCtD
Pregabalin—Pain—Docetaxel—head and neck cancer	0.000648	0.000648	CcSEcCtD
Pregabalin—Constipation—Docetaxel—head and neck cancer	0.000648	0.000648	CcSEcCtD
Pregabalin—Feeling abnormal—Docetaxel—head and neck cancer	0.000624	0.000624	CcSEcCtD
Pregabalin—Nausea—Fluorouracil—head and neck cancer	0.000623	0.000623	CcSEcCtD
Pregabalin—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000619	0.000619	CcSEcCtD
Pregabalin—Abdominal pain—Docetaxel—head and neck cancer	0.000599	0.000599	CcSEcCtD
Pregabalin—Body temperature increased—Docetaxel—head and neck cancer	0.000599	0.000599	CcSEcCtD
Pregabalin—Hypersensitivity—Docetaxel—head and neck cancer	0.000558	0.000558	CcSEcCtD
Pregabalin—Asthenia—Docetaxel—head and neck cancer	0.000543	0.000543	CcSEcCtD
Pregabalin—Pruritus—Docetaxel—head and neck cancer	0.000536	0.000536	CcSEcCtD
Pregabalin—Diarrhoea—Docetaxel—head and neck cancer	0.000518	0.000518	CcSEcCtD
Pregabalin—Dizziness—Docetaxel—head and neck cancer	0.000501	0.000501	CcSEcCtD
Pregabalin—Vomiting—Docetaxel—head and neck cancer	0.000481	0.000481	CcSEcCtD
Pregabalin—Rash—Docetaxel—head and neck cancer	0.000477	0.000477	CcSEcCtD
Pregabalin—Dermatitis—Docetaxel—head and neck cancer	0.000477	0.000477	CcSEcCtD
Pregabalin—Headache—Docetaxel—head and neck cancer	0.000474	0.000474	CcSEcCtD
Pregabalin—Nausea—Docetaxel—head and neck cancer	0.00045	0.00045	CcSEcCtD
